Pasithea Therapeutics (KTTA) Cash from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics (KTTA) posted Cash from Discontinued Operations of 16895.0 for Q4 2023, down 50.18% sequentially from 11250.0 in Q3 2023, and up 97.8% YoY from 8541.24 in Q4 2022.
Pasithea Therapeutics (KTTA) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Pasithea Therapeutics has reported Cash from Discontinued Operations for 2 years, with the latest figure at 16895.0 in Q4 2023.
- Quarterly Cash from Discontinued Operations rose 97.8% year-over-year to 16895.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 611278.0 (up 65.98% YoY) and the FY2023 annual result came in at 611278.0, up 65.98% from the prior year.
- Cash from Discontinued Operations eased to 16895.0 in Q4 2023 per KTTA's latest filing, from 11250.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 10698.0 in Q2 2022 and troughed at 769680.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -16,895.00 |
| Dec 31, 2023 | -16,895.00 |
| Sep 30, 2023 | -11,250.00 |
| Sep 30, 2023 | -11,250.00 |
| Jun 30, 2023 | -399,689.00 |
| Jun 30, 2023 | -399,689.00 |
| Mar 31, 2023 | -183,444.00 |
| Mar 31, 2023 | -183,444.00 |
| Dec 31, 2022 | -769,680.00 |
| Dec 31, 2022 | -769,680.00 |
| Sep 30, 2022 | -626,357.00 |
| Sep 30, 2022 | -626,357.00 |
| Jun 30, 2022 | 10,698.00 |
| Jun 30, 2022 | 10,698.00 |
| Mar 31, 2022 | -411,252.00 |
| Mar 31, 2022 | -411,252.00 |